Last reviewed · How we verify
GSK1605786 ChemoCentryx: formulation A
At a glance
| Generic name | GSK1605786 ChemoCentryx: formulation A |
|---|
| Sponsor | GlaxoSmithKline |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.